Aug 13, 2020 | Inpatient Psych
CMS issued the FY 2021 final rule for the inpatient psychiatric facility (IPF) payment system. CMS will increase IPF payments by a net +2.3%, or $95M—below the initial proposal, as CMS expects COVID-19 impacts on the economy to drive slower compensation growth and reduce the estimated market basket update. Click to read more.
May 5, 2020 | Home Care, Home Health, Hospitals, Inpatient, Inpatient Psych, Inpatient Rehab (IRF), Medicaid, Medicare, Outpatient, Physical Therapy, Post-Acute Care
On April 30, CMS issued its second round of regulatory waivers and changes to increase access to testing and provide greater flexibilities to support care delivery in the wake of COVID-19, including for telehealth services, hospitals, ACOs, home health, and therapists. Click to read more.
Apr 15, 2020 | Inpatient Psych, Medicare
CMS indicates that they are proposing rules with minimal policy changes in order to alleviate regulatory burden on providers due to COVID19. This brief summarizes the FY 2021 proposed rule for Inpatient Psychiatric Facilities (IPFs). Click to read more.
Mar 18, 2020 | Behavioral, Hospitals, Physicians
The Coronavirus is dramatically affecting the way healthcare is administered in the US forcing hospitals and physician groups to make tough decisions about who they see and who they don’t, but it’s also giving way to innovation and collaboration that may represent some hope and a path to a new era in healthcare delivery. Our health policy and market research group on Tuesday surveyed 200 healthcare leaders who are literally in the throes of crisis management, representing a sample of the nation’s leading systems, payers and physician groups and ‘on the ground’ clinical teams. We will be...
Dec 4, 2019 | Behavioral, Medicare, Substance Abuse
CMS has finalized a bundled payment under the PFS for OUD treatment office-based services for 2020. This approach parallels the new bundled OUD treatment services for OTPs. Click to read more.
Nov 19, 2019 | Behavioral, Inpatient Psych, Medicaid, Substance Abuse
On November 6th, CMS announced the approval of DC’s Medicaid 1115 Waiver that expands access to behavioral health treatment. This waiver, which will go into effect on January 1, 2020, will broaden services available to beneficiaries diagnosed with serious mental illness (SMI) or serious emotional disturbance (SED) and provide new services for beneficiaries diagnosed with substance use disorder (SUD). Click to read more.